Fairmount Funds Management LLC bought COGT
July 10, 2025 · Form 4 insider transaction
Fairmount Funds Management LLC bought 2,777,777 shares of Cogent Biosciences, Inc. at $9.00 per share, a transaction worth $25.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,777,777
Price
$9.00
Total value
$25.00M
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 10, 2025
Filing dateJuly 14, 2025
Shares owned after9,003,418
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.